Turkiye Klinikleri Journal of Internal Medicine

.: ORIGINAL RESEARCH
The Prevalence and Etiology of Hepatic Granulomas in Turkey: A Systematic Review
Türkiye'de Hepatik Granülomlarin Prevalansı ve Etiyolojisi: Bir Sistematik Derleme
Süleyman URAZa, Esra ZERDALİb, Aslıhan DEMİRELc, Bilgül METEd, Fehmi TABAKd, Reşat ÖZARASe
aDepartment of Gastroenterology, Demiroğlu Bilim University Faculty of Medicine, İstanbul, TURKEY
bDepartment of Infectious Diseases and Clinical Microbiology, University of Health Sciences Haseki Education and Research Hospital, İstanbul, TURKEY
cDepartment of Infectious Diseases and Clinical Microbiology, Demiroğlu Bilim University Faculty of Medicine, İstanbul, TURKEY
dDepartment of Infectious Diseases and Clinical Microbiology, İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, İstanbul, TURKEY
eClinic of Infectious Diseases and Clinical Microbiology, Medilife Hospital, İstanbul, TURKEY
Turkiye Klinikleri J Intern Med. 2020;5(3):97-104.
doi: 10.5336/intermed.2020-75613
Article Language: EN
Full Text
ABSTRACT
 Objective: Hepatic granulomas (HGs) are seen in 2- 4% of liver biopsies and the etiology is heterogeneous including liver involvement in systemic immunologic disorders and infectious diseases, primary hepatic diseases, drug hepatotoxicity, foreign bodies, and reaction to neoplastic disease. Common etiologies are primary biliary cholangitis (PBC) and sarcoidosis in the Western world, while infections especially tuberculosis (TB) preclude in the Eastern countries. In Turkey, HGs have been reported in 2-5% of liver biopsies and the etiology includes both infections and non-infectious diseases. In this review, we aimed to determine the prevalence and etiology of HGs in Turkey. Material and Methods: A search of Pubmed, Scopus and Science Citation Index and national databses (including Tübitak Ulakbim, Türkmedline, and Türk Atıf Dizini) was done and 60 reports were reached. Four studies from Turkey dedicated to describe the rate of HGs and their etiology were determined. Results: The rate of HGs is 2.27% (208/9164). Infections as a group (TB, hydatid disease, HCV, brucellosis, fascioliasis, typhoid fever, fungal infection, HBV, actinomycosis, yersiniosis, leishmaniasis, and infectious mononucleosis) were the etiology in 38.4%. PBC was the leading etiology, followed by sarcoidosis, TB, and hydatid disease. Beside the dedicated HG series, 11 series from Turkey included cases with HGs and 45 papers described 52 case reports with HGs. Conclusion: HGs are seen in 2.3% of the liver biopsies in Turkey. The infections still represent the leading etiology and among them, TB appears the commonest one. When the cases are evaluated individually, PBC is the leading etiology. Infections are followed by PBC and sarcoidosis, which are main two etiologies of HGs in the world. The local and regional epidemiology of certain infectious diseases, particularly TB determines the etiologic distribution of HGs.

Keywords: Hepatic granuloma; Turkey; primary biliary cholangitis; sarcoidosis
ÖZET
 Amaç: Karaciğer biyopsilerinin %2-4'ünde, karaciğer granülom (KG)ları görülür. KG'lerin, sistemik immünolojik bozukluklar, enfeksiyon hastalıkları, primer hepatik hastalıklar, ilaç hepatotoksisitesi, yabancı cisimler ve neoplastik hastalığa reaksiyon gibi geniş bir etiyolojisi vardır. Yaygın etiyolojiler, Batı dünyasında primer biliyer kolanjit (PBK) ve sarkoidoz olup, Doğu ülkelerinde ise enfeksiyon hastalıkları, özellikle tüberküloz ön plana çıkmaktadır. Türkiye'de de karaciğer biyopsilerinin %2-5'inde KG bildirilmiş olup; etiyolojisi, hem enfeksiyonları hem de enfeksiyon dışı nedenleri içermektedir. Bu derlemede, Türkiye'deki KG prevalansını ve etiyolojisini belirlemeyi amaçladık. Gereç ve Yöntemler: PubMed, Scopus, Science Citation Index ve ulusal indekslerin (TÜBİTAK ULAKBİM, Türk Medline ve Türk Atıf Dizini) araştırması yapıldı ve 60 rapora ulaşıldı. Türkiye'den, KG'lerin oranını ve etiyolojisini tanımlamaya yönelik 4 çalışma belirlenmiştir. Bulgular: KG oranı %2,27'dir (208/9164). Grup olarak enfeksiyonlar (tüberküloz, hidatik kist, hepatit C virüsü, bruselloz, fasiolazis, tifo, mantar enfeksiyonu, hepatit B virüsü, aktinomikoz, yersiniyoz, leyişmanyoz ve enfeksiyöz mononükleoz), olguların %38,4'ünün etiyolojisini oluşturmaktadır. Hastalıklar tek tek ele alındığında PBK, önde gelen etiyolojidir ve onu sarkoidoz, tüberküloz ve hidatik kist izlemektedir. KG'ye özgü serilerin yanı sıra Türkiye'den 11 seride, KG içeren olgular vardı. Ayrıca 45 çalışmada, KG'li 52 olgu bildirimi mevcuttu. Sonuç: KG'ler, Türkiye'deki karaciğer biyopsilerinin %2,3'ünde görülür. Enfeksiyonlar, hâlâ önde gelen etiyolojiyi temsil etmekte olup, aralarında tüberküloz en yaygın olanıdır. Hastalıklar, tek tek ele alındığında PBK önde gelen etiyolojidir. Enfeksiyonları, dünyadaki KG'lerin ana 2 etiyolojisi olan PBK ve sarkoidoz takip eder. Bazı enfeksiyöz hastalıkların, özellikle tüberkülozun lokal ve bölgesel epidemiyolojisi, KG'lerin etiyolojik dağılımını belirler.

Anahtar Kelimeler: Karaciğer granülomları; Türkiye; safra sirozu; sarkoidoz
REFERENCES:
  1. Lagana SM, Moreira RK, Lefkowitch JH. Hepatic granulomas: pathogenesis and differential diagnosis. Clin Liver Dis. 2010;14(4):605-17.[Crossref] [PubMed] 
  2. Flamm SL. Granulomatous liver disease. Clin Liver Dis. 2012;16(2):387-96.[Crossref] [PubMed] 
  3. Wainwright H. Hepatic granulomas. Eur J Gastroenterol Hepatol. 2007;19(2):93-5.[Crossref] [PubMed] 
  4. Drebber U, Kasper HU, Ratering J, Wedemeyer I, Schirmacher P, Dienes HP, et al. Hepatic granulomas: histological and molecular pathological approach to differential diagnosis--a study of 442 cases. Liver Int. 2008;28(6):828-34.[Crossref] [PubMed] 
  5. McCluggage WG, Sloan JM. Hepatic granulomas in Northern Ireland: a thirteen year review. Histopathology. 1994;25(3):219-28.[Crossref] [PubMed] 
  6. Gaya DR, Thorburn D, Oien KA, Morris AJ, Stanley AJ. Hepatic granulomas: a 10 year single centre experience. J Clin Pathol. 2003;56(11):850-3.[Crossref] [PubMed] [PMC] 
  7. Dourakis SP, Saramadou R, Alexopoulou A, Kafiri G, Deutsch M, Koskinas J, et al. Hepatic granulomas: a 6-year experience in a single center in Greece. Eur J Gastroenterol Hepatol. 2007;19(2):101-4.[Crossref] [PubMed] 
  8. Satti MB, al-Freihi H, Ibrahim EM, Abu-Melha A, al-Ghassab G, al-Idrissi HY, et al. Hepatic granuloma in Saudi Arabia: a clinicopathological study of 59 cases. Am J Gastroenterol. 1990;85(6):669-74.[PubMed] 
  9. Geramizadeh B, Jahangiri R, Moradi E. Causes of hepatic granuloma: a 12-year single center experience from southern Iran. Arch Iran Med. 2011;14(4):288-9.[PubMed] 
  10. Chong RS, Ng HS, Teh LB, Ho JM. Hepatic granulomas--an experience over the last 8 years. Singapore Med J. 1990;31(5):422-6.[PubMed] 
  11. Sabharwal BD, Malhotra N, Garg R, Malhotra V. Granulomatous hepatitis: a retrospective study. Indian J Pathol Microbiol. 1995;38(4):413-6.[PubMed] 
  12. Sanai FM, Ashraf S, Abdo AA, Satti MB, Batwa F, Al-Husseini H, et al. Hepatic granuloma: decreasing trend in a high-incidence area. Liver Int. 2008;28(10):1402-7.[Crossref] [PubMed] 
  13. Ozaras R, Yemisen M, Balkan II. More on hepatic granulomas. Diagn Pathol. 2015;10:203.[Crossref] [PubMed] [PMC] 
  14. Mert A, Ozaras R, Bilir M, Tahan V, Cetinkaya A, Yirmibescik S, et al. The etiology of hepatic granulomas. J Clin Gastroenterol. 2001;32(3):275-6.[Crossref] [PubMed] 
  15. Onal IK, Ersoy O, Aydinli M, Yonem O, Harmanci O, Sokmensuer C, Bayraktar Y. Hepatic granuloma in Turkish adults: a report of 13 cases. Eur J Intern Med. 2008;19(7):527-30.[Crossref] [PubMed] 
  16. Turhan N, Kurt M, Ozderin YO, Kurt OK. Hepatic granulomas: a clinicopathologic analysis of 86 cases. Pathol Res Pract. 2011;207(6):359-65.[Crossref] [PubMed] 
  17. Sahin M, Yılmaz G, Arhan M, Sen I. Hepatic granulomas in Turkey: a 6-year clinicopathological study of 35 cases. Turk J Gastroenterol. 2014;25(5):524-8.[Crossref] [PubMed] 
  18. Balci NC, Tunaci A, Akinci A, Cevikbaş U. Granulomatous hepatitis: MRI findings. Magn Reson Imaging. 2001;19(8):1107-11.[Crossref] [PubMed] 
  19. Kaplan KJ, Goodman ZD, Ishak KG. Eosinophilic granuloma of the liver: a characteristic lesion with relationship to visceral larva migrans. Am J Surg Pathol. 2001;25(10):1316-21.[Crossref] [PubMed] 
  20. Mert A, Bilir M, Tabak F, Ozaras R, Ozturk R, Senturk H, et al. Miliary tuberculosis: clinical manifestations, diagnosis and outcome in 38 adults. Respirology. 2001;6(3):217-24.[Crossref] [PubMed] 
  21. Mert A, Ozaras R, Bilir M, Tabak F, Aki H, Ozturk R. Ziehl-Neelsen staining and polymerase chain reaction study of tissue from tuberculous granulomas. Respirology. 2003;8(4):548.[Crossref] [PubMed] 
  22. Ozaras R, Tahan V, Mert A, Uraz S, Kanat M, Tabak F, et al. The prevalence of hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol. 2004;38(5):449-52.[Crossref] [PubMed] 
  23. Saltoglu N, Tasova Y, Midikli D, Aksu HS, Sanli A, Dündar IH. Fever of unknown origin in Turkey: evaluation of 87 cases during a nine-year-period of study. J Infect. 2004;48(1):81-5.[Crossref] [PubMed] 
  24. Tahan V, Ozaras R, Lacevic N, Ozden E, Yemisen M, Ozdogan O, et al. Prevalence of hepatic granulomas in chronic hepatitis B. Dig Dis Sci. 2004;49(10):1575-7.[Crossref] [PubMed] 
  25. Savas N, Coskun M, Bilezikci B, Uruc I, Karakayali H, Yilmaz U, et al. Value of an individual liver biopsy in the preoperative evaluation of apparently healthy potential liver donors. Liver Transpl. 2008;14(4):541-6.[Crossref] [PubMed] 
  26. Gezer NS, Başara I, Altay C, Harman M, Rocher L, Karabulut N, Seçil M. Abdominal sarcoidosis: cross-sectional imaging findings. Diagn Interv Radiol. 2015;21(2):111-7.[Crossref] [PubMed] [PMC] 
  27. Suvak B, Dulger AC, Karadas S, Gonullu H, Bayram Y, Gonullu E, et al. Brucellosis-related acute pancreatitis: A rare complication of a universal disease. J Int Med Res. 2016;44(1):131-5.[Crossref] [PubMed] [PMC] 
  28. Mert A, Yılmaz M, Ceylan B, Aslan F. Hepatic granulomas: etiologic distribution. Turk J Gastroenterol. 2014;25(5):529-30.[Crossref] [PubMed] 
  29. Gündoğdu ZH, Senocak ME, Cağlar M, Büyükpamukçu N. Isolated hepatic granuloma mimicking congenital simple cyst of the liver possibly caused by tuberculosis. J Pediatr Surg. 1992;27(12):1553-6.[Crossref] [PubMed] 
  30. Emre A, Akpinar E, Acarli K, Alper A, Cevikbaş U, Arioğul O. Primary solitary tuberculosis of the liver. HPB Surg. 1992;5(4):261-4.[Crossref] [PubMed] [PMC] 
  31. Ozbakkaloglu B, Tünger O, Sürücüoglu S, Lekili M, Kandiloglu AR. Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy. Int Urol Nephrol. 1999;31(1):49-53.[Crossref] [PubMed] 
  32. Mert A, Tabak F, Ozaras R, Tahan V, Senturk H, Ozbay G. Hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol. 2001;33(4):342-3.[Crossref] [PubMed] 
  33. Erten N, Saka B, Artinesen B, Akif Karan M, Kilicarslan I, Tascioglu C. Extrapulmonary sarcoidosis with chronic renal failure. Eur J Intern Med. 2003;14(4):262-4.[Crossref] [PubMed] 
  34. Mert A, Ozaras R, Tabak F, Ozturk R, Bilir M. Localized hepatic tuberculosis. Eur J Intern Med. 2003;14(8):511-2.[Crossref] [PubMed] 
  35. Akçay MN, Polat KY, Oren D, Oztürk G. Primary tuberculous liver abscess. A case report and review of literature. Int J Clin Pract. 2004;58(6):625-7.[Crossref] [PubMed] 
  36. Mert A, Tabak F, Ozaras R, Ozturk R, Aki H, Aktuglu Y. Typhoid fever as a rare cause of hepatic, splenic, and bone marrow granulomas. Intern Med. 2004;43(5):436-9.[Crossref] [PubMed] 
  37. Sen M, Turan M, Karadayi K, Ugurlu L, Elagoz S. Isolated hepatic tuberculous pseudometastasis co-existent with adenocarcinoma of the stomach; report of a case. Acta Chir Belg. 2004;104(5):601-3.[Crossref] [PubMed] 
  38. Soylu A, Türkmen M, Kasap B, Sarioğlu S, Saatçi AO, Büyükgebiz B, et al. Sarcoidosis with an uncommon presentation: apropos of a case. Turk J Pediatr. 2004;46(4):366-9.[PubMed] 
  39. Akcam M, Artan R, Yilmaz A, Cig H, Aksoy NH. Abdominal tuberculosis in adolescents. Difficulties in diagnosis. Saudi Med J. 2005;26(1):122-6.[PubMed] 
  40. Poyanli A, Bilge O, Kapran Y, Güven K. Case report: Foreign body granuloma mimicking liver metastasis. Br J Radiol. 2005;78(932):752-4.[Crossref] [PubMed] 
  41. Akay BN, Ekmekci P, Sanli H, Celik G, Bozdayi M. Cutaneous, pulmonary and hepatic sarcoidosis associated with autoimmune complications during interferon-alpha treatment for hepatitis C virus infection. J Eur Acad Dermatol Venereol. 2006;20(4):442-5.[Crossref] [PubMed] 
  42. Dede F, Doğan E, Demir M, Sener D, Kös M, Tad M, et al. Unusual presentation of tuberculosis as a splenic mass. Tohoku J Exp Med. 2006;210(1):79-82.[Crossref] [PubMed] 
  43. Ersoy O, Aran R, Aydinli M, Yonem O, Harmanci O, Akdogan B, et al. Granulomatous hepatitis after intravesical BCG treatment for bladder cancer. Indian J Gastroenterol. 2006;25(5):258-9.[PubMed] 
  44. Inan M, Sakru N, Vatansever U, Bilgi S. Visceral larva migrans presenting as acute abdomen in a child. J Pediatr Surg. 2006;41(3):e7-9.[Crossref] [PubMed] 
  45. Köksal D, Köksal AS, Köklü S, Ciçek B, Altiparmak E, Sahin B. Primary tuberculous liver abscess: a case report and review of the literature. South Med J. 2006;99(4):393-5.[Crossref] [PubMed] 
  46. Parsak CK, Hanta I, Aslan A, Alabaz O. Isolated hepatic tuberculosis presenting as cystic-like and tumour-like mass lesions. Case Rep Gastroenterol. 2008;2(1):18-21.[Crossref] [PubMed] [PMC] 
  47. Yazici P, Yeniay L, Aydin U, Taşbakan M, Ozütemiz O, Yilmaz R. Visceral leishmaniasis as a rare cause of granulomatosis hepatitis: a case report. Turkiye Parazitol Derg. 2008;32(1):12-5.[PubMed] 
  48. Alabaz D, Kibar F, Arikan S, Sancak B, Celik U, Aksaray N, et al. Systemic phaeohyphomycosis due to Exophiala (Wangiella) in an immunocompetent child. Med Mycol. 2009;47(6):653-7.[Crossref] [PubMed] 
  49. Egritas O, Sari S, Dalgic B, Vural C, Akyol G. Granulomatous hepatitis, perihepatic lymphadenopathies, and autoantibody positivity: an unusual association in a child with hepatitis C. Eur J Pediatr. 2009;168(3):275-9.[Crossref] [PubMed] 
  50. Dursun I, Yıkılmaz A, Poyrazoglu H, Soyuer I, Gunduz Z. Radiological findings of isolated hepatic tuberculosis in a child with tubulointerstitial nephritis-uveitis syndrome. Pediatr Radiol. 2009;39(3):302-5.[Crossref] [PubMed] 
  51. Soylu A, Ince AT, Polat H, Yasar N, Ciltas A, Ozkara S, et al. Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin. Ann Clin Microbiol Antimicrob. 2009;8:12.[Crossref] [PubMed] [PMC] 
  52. Cetinkaya Z, Kocakoc E, Coskun S, Ozercan IH. Primary hepatic actinomycosis. Med Princ Pract. 2010;19(3):196-9.[Crossref] [PubMed] 
  53. Ince V, Ara C, Koç C, Ersan V, Barut B. [Fasciola hepatica mimicking malignancy of the liver and colon: three case reports]. ınönü Üniversitesi Tıp Fakültesi Dergisi 2010;17(3):207-10. https://www.bibliomed.org/mnsfulltext/134/2010_17_3_9.pdf?1605187188
  54. Önal ıK, Akdoğan M, Aypak A, Oğuz P, Temuçin Keklik T, Öztaş E, et al. Granulomatous hepatitis as a rare complication of intravesical BCG therapy for bladder cancer: case report. Turkiye Klinikleri J Med Sci. 2010;30(3):1092-5.[Crossref] 
  55. Ozin Y, Parlak E, Kiliç ZM, Temuçin T, Saşmaz N. Sclerosing cholangitis-like changes in hepatobiliary tuberculosis. Turk J Gastroenterol. 2010;21(1):50-3.[Crossref] [PubMed] 
  56. Sevinç AI, Unek T, Astarcioğlu H. Inflammatory myofibroblastic tumour (IMT) of the liver: a report of two cases. Acta Chir Belg. 2010;110(1):87-9.[Crossref] [PubMed] 
  57. Karaman A, Samdancı E, Doğan M, Aksoy RT, Sığırcı A, Demircan M. Xanthogranulomatous pyelonephritis with unconnected liver lesion. Urology. 2011;78(1):189-91.[Crossref] [PubMed] 
  58. Şişman G, Hatemi İ, Özbay G, Özdemir S. [A case of hepatotoxicity which occured after pioglitazone therapy and co-diagnosis of primary biliary cirrhosis: case report]. Turkiye Klinikleri J Gastroenterohepatol. 2011;18(2):91-3. https://turkiyeklinikleri.com/article/tr-pioglitazon-kullanimi-sonrasinda-gelisen-hepatotoksisite-ve-beraberinde-saptanan-primer-biliyer-siroz-vakasi-61996.html
  59. Haltaş H, Yenidünya S, Akın K, Bayrak R, İnan A, Aşık F. Acute cholecystitis with granulomatous hepatitis as atypical clinic presentation of brucellosis: case report and review of literature. Turkiye Klinikleri J Gastroenterohepatol. 2012;19(1):47-51. https://www.turkiyeklinikleri.com/article/en-acute-cholecystitis-with-granulomatous-hepatitis-as-atypical-clinic-presentation-of-brucellosis-case-report-and-review-of-literature-63587.html
  60. Anar CM, Büyükşirin M, Erer OF, Yavaşoğlu G, Halilçolar H. [A case of tuberculosis effusion and lymphadenitis followed by the development of a hepatic abscess during treatment with antituberculosis drugs]. Solunum. 2013;15(1):60-5. https://www.journalagent.com/eurasianjpulmonol/pdfs/SOLUNUM_15_1_60_65.pdf
  61. Ekiz E, Colak Y, Tuncer I. A rare case of fever of unknown origin. Idiopathic granulomatous hepatitis. Saudi Med J. 2014;35(5):510-1.[PubMed] 
  62. Taşbakan MI, Erdem HA, Pullukçu H, Yamazhan T, Sipahi OR, Taşbakan MS, et al. Isolated hepatic sarcoidosis mimicking liver microabscesses: a case report. Ir J Med Sci. 2014;183(3):503-5.[Crossref] [PubMed] 
  63. Türkel Küçükmetin N, Ince U, Ciçek B, Akman H, Boztaş G, Tözün N. Isolated hepatic tuberculosis: a rare cause of hepatic mass lesions. Turk J Gastroenterol. 2014;25(1):110-2.[Crossref] [PubMed] 
  64. Çalışkan B, Somer A, Hatipoğlu N, Keser M, Yekeler E, Gün F, et al. Tuberculous liver abscess in an immunocompetent child with pulmonary tuberculosis as a cause of fever of unknown origin. Turk J Pediatr. 2015;57(1):85-9.[PubMed] 
  65. Kayar Y, Ekinci I, Turkdogan FT, Atay M, Soytas RB, Kayar NB. A rare case of isolated macronodular hepatic tuberculosis (Tuberculous) in an immunocompetent patient. J Pak Med Assoc. 2015;65(11):1235-6.[PubMed] 
  66. Ufuk F, Herek D. CT of Hepatic sarcoidosis: small nodular lesions simulating metastatic disease. Pol J Radiol. 2015;80:945-54.[Crossref] [PubMed] [PMC] 
  67. Koklu H, Koklu S, Ozturk O, Kahramanoglu Aksoy E, Karcaaltıncaba M, Sokmensuer C. Cirrhosis related to hepatic sarcoidosis in older adults. J Am Geriatr Soc. 2016;64(8):1747-8.[Crossref] [PubMed] 
  68. Eren Akarcan S, Karaca N, Aksu G, Bozkaya H, Ayik MF, Ozdemir Sahan Y, et al. Necrotizing liver granuloma/abscess and constrictive aspergillosis pericarditis with central nervous system involvement: different remarkable phenotypes in different chronic granulomatous disease genotypes. Case Reports Immunol. 2017;2017:2676403.[Crossref] [PubMed] [PMC] 
  69. Köklü H, Armağan B, Karadağ Ö, Karcaaltıncaba M, Özgen Kıratlı MP, Gedikoğlu G, et al. Multiple liver masses mimicking metastatic liver disease in an elderly patient. Turk J Gastroenterol. 2018;29(1):119-22.[Crossref] [PubMed] [PMC] 
  70. Özgüven BY, Tunçel D, Kabukçuoğlu F, Özdemir S, Alkım C. Sarcoidosis with hepatic involvement: a case report. Sisli Etfal Hastan Tip Bul. 2018;52(1):54-6.[Crossref] [PubMed] [PMC] 
  71. Yıldırım Ç, Otman Akat E, Işıkgöz Taşbakan M, Sipahi OR, Pullukuçu H, Yamazhan T. [Acute cholecystitis and granulamatous hepatitis caused by Brucella Melitensis]. Turkiye Klinikleri J Med Sci. 2018;38(1):79-83.[Crossref] 
  72. Bayramoglu Z, Adaletli I, Caliskan E, Acar M, Hancerli Torun S, Somer A. Severe multisystem involvement of chronic granulomatous disease in a pediatric patient. J Trop Pediatr. 2019;65(2):192-5.[Crossref] [PubMed] 
  73. Şamdanci E, Şahin N, Dağli AF, Akatli AN, Aydin NE. Fascioliasis: a rare parasitic infection-mimicking tumor in the liver: report of two cases. Turk Patoloji Derg. 2019;35(1):58-60.[Crossref] [PubMed] 
  74. Kocabaş E, Özgür Gündeşlioğlu Ö, Kılıç Çil M, Çay Ü, Doran F, Soyupak S. A rare cause of granulomatous hepatitis: Tularemia. J Infect Public Health. 2020;13(7):1003-5.[Crossref] [PubMed] 
  75. Tannapfel A, Dienes HP, Lohse AW. The indications for liver biopsy. Dtsch Arztebl Int. 2012;109(27-28):477-83.[Crossref] [PubMed] [PMC] 
  76. Amarapurkar D, Amarapurkar A. Indications of liver biopsy in the era of noninvasive assessment of liver fibrosis. J Clin Exp Hepatol. 2015;5(4):314-9.[Crossref] [PubMed] [PMC] 
  77. You Z, Wang Q, Bian Z, Liu Y, Han X, Peng Y, et al. The immunopathology of liver granulomas in primary biliary cirrhosis. J Autoimmun. 2012;39(3):216-21.[Crossref] [PubMed] [PMC] 
  78. Reshetnyak VI. Primary biliary cirrhosis: clinical and laboratory criteria for its diagnosis. World J Gastroenterol. 2015;21(25):7683-708.[Crossref] [PubMed] [PMC] 
  79. Musellim B, Kumbasar OO, Ongen G, Cetinkaya E, Turker H, Uzaslan E, et al. Epidemiological features of Turkish patients with sarcoidosis. Respir Med. 2009;103(6):907-12[Crossref] [PubMed] 
  80. WHO. Global Tuberculosis Report 2020. (Accessed 20 January 2020) https://www.who.int/tb/publications/global_report/en/
  81. Gaspar R, Andrade P, Silva M, Peixoto A, Lopes J, Carneiro F, et al. Hepatic granulomas: a 17-year single tertiary centre experience. Histopathology. 2018;73(2):240-6.[Crossref] [PubMed] 
  82. Voigt JJ, Cassigneul J, Delsol G, Vinel JP, Pau H, Fabre J. [Granulomatous hepatitis. Apropos of 112 cases in adults]. Ann Pathol. 1984;4(1):78-80.[PubMed] 
  83. Martin-Blondel G, Camara B, Selves J, Robic MA, Thebault S, Bonnet D, et al. [Etiology and outcome of liver granulomatosis: a retrospective study of 21 cases]. Rev Med Interne. 201;31(2):97-106.[Crossref] [PubMed] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com